BCAL Diagnostics Ltd banner

BCAL Diagnostics Ltd
ASX:BDX

Watchlist Manager
BCAL Diagnostics Ltd Logo
BCAL Diagnostics Ltd
ASX:BDX
Watchlist
Price: 0.083 AUD Market Closed
Market Cap: AU$30.6m

Wall Street
Price Targets

BDX Price Targets Summary
BCAL Diagnostics Ltd

There are no price targets for BDX.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
BCAL Diagnostics Ltd Competitors:
Price Targets
TTD
Trade Desk Inc
45% Upside

Revenue
Forecast

49% / Year
Past Growth
15% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
49% / Year
Past Growth
15% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

For the last 6 years the compound annual growth rate for BCAL Diagnostics Ltd's revenue is 49%. The projected CAGR for the next 3 years is 15%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BDX's stock price target?
Not Available

BDX doesn't have any price targets made by Wall Street professionals.

What is BCAL Diagnostics Ltd's Revenue forecast?
Projected CAGR
15%

For the last 6 years the compound annual growth rate for BCAL Diagnostics Ltd's revenue is 49%. The projected CAGR for the next 3 years is 15%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett